Prosecution Insights
Last updated: November 20, 2026

Julie Ha, USPTO Patent Examiner

Listed by the USPTO as HA, JULIE

Tech Center 1600 • Art Units: 1647 1654 1658 1675

This examiner grants 76% of resolved cases

Analysis

HA, JULIE works in Technology Center 1600 and Art Unit 1647. The profile records 1128 resolved cases, a 75.7% allowance rate, and a 44.1% interview lift. The median time to allowance is 953 days. The breadth of the record supports using these figures as a meaningful historical reference, while the interview result highlights the potential value of direct examiner engagement.

The listed companies are The Regents of the University of California, Eli Lilly and Company, and Zhejiang University. The listed firms are BALLARD SPAHR LLP, NOVICK, KIM & LEE, PLLC, dba NKL Law, and DORITY & MANNING, P.A. Counsel can review those participants for relevant drafting and prosecution experience, then tailor interview preparation to the application's technical and claim issues.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

75.7%
Allow Rate
+15.7% vs TC avg
1,175
Total Applications
+44.1%
Interview Lift
953
Avg Prosecution Days
Based on 1128 resolved cases, 2023–2026

Rejection Statute Breakdown

8.0%
§101 Eligibility
21.3%
§102 Novelty
21.5%
§103 Obviousness
34.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18292207 BARRIER FUNCTION PRESERVING PEPTIDES FOR MEMBRANES Non-Final OA The Regents of the University of California
18518981 Treatment of Glaucoma by Neuroprotection Non-Final OA The Regents of the University of California
17442831 COMPOSITIONS AND METHODS OF TREATING AND PREVENTING SYSTEMIC COMPLICATIONS OF ACUTE ILLNESS Non-Final OA THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
18726124 POLYPEPTIDE AND APPLICATION THEREOF IN PREPARATION OF ANTI-FIBROSIS DRUG Non-Final OA Zhejiang University
18477878 CASPASE INHIBITION TO ENHANCE REGENERATION AND REPAIR AFTER SKIN OR GUT INJURY AND TO TREAT BACTERIAL OR VIRAL INFECTIONS Final Rejection The Johns Hopkins University
17755939 USE OF ALPHA-LACTALBUMIN ENRICHED WHEY PROTEIN EXTRACT AS A SOURCE OF CHOLESTEROL Non-Final OA SOCIETE DES PRODUITS NESTLE S.A.
18620631 PD-1 AGONIST Non-Final OA GEORGE MASON UNIVERSITY
18280186 APPLICATION OF APOPTOSIS INHIBITOR 5 (API5) FOR EPITHELIAL RESTITUTION Non-Final OA New York University
18264967 AMINO ACID-BASED GLASS, PREPARATION METHOD AND USE THEREOF Final Rejection INSTITUTE OF PROCESS ENGINEERING, CHINESE ACADEMY OF SCIENCES
17908015 Undenatured Type II Collagen in Food and Beverage Applications and Uses Thereof Non-Final OA Lonza Greenwood LLC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Julie Ha's allowance rate?

75.7% of resolved applications examined by Julie Ha were allowed (1,128 resolved cases), compared with 39.9% across Art Unit 1647 over the last five years.

Does an interview help with examiner Julie Ha?

This examiner's interview lift is +44.1 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Julie Ha take to allow a patent?

Applications allowed by Julie Ha took 953 days on average from filing to allowance.

Which art unit does examiner Julie Ha work in?

Julie Ha examines applications in Art Unit 1647 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month